{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:31:52Z","timestamp":1789684312119,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Clinical Research Improvement Plan Project of Zhuhai People's Hospital in 2023","award":["2023LCTS-19"],"award-info":[{"award-number":["2023LCTS-19"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]},{"name":"Social Development Technology Plan Project of Zhuhai City in 2024","award":["2420004000130"],"award-info":[{"award-number":["2420004000130"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02276-7","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:33:31Z","timestamp":1741332811000},"page":"3446-3457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["USP5 Deletion Inhibits KD Serum Induced-Human Coronary Artery Endothelial Cell Dysfunction by Regulating the NFATC1\/TLR4-Mediated NF-\u03baB Signaling Pathway in Kawasaki Disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Lidan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"10","key":"2276_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","volume":"22","author":"E Rife","year":"2020","unstructured":"Rife, E., and A. Gedalia. 2020. Kawasaki disease: An update. Current Rheumatology Reports 22 (10): 75.","journal-title":"Current Rheumatology Reports"},{"key":"2276_CR2","doi-asserted-by":"publisher","first-page":"694393","DOI":"10.3389\/fcvm.2021.694393","volume":"8","author":"AZ Banday","year":"2021","unstructured":"Banday, A.Z., S. Mondal, P. Barman, A. Sil, R. Kumrah, P. Vignesh, and S. Singh. 2021. What lies ahead for young hearts in the 21(st) century - is it double trouble of acute rheumatic fever and Kawasaki disease in developing countries? Frontiers in Cardiovascular Medicine 8:694393.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"10","key":"2276_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/1744666X.2019.1659726","volume":"15","author":"AK Jindal","year":"2019","unstructured":"Jindal, A.K., R.K. Pilania, A. Prithvi, S. Guleria, and S. Singh. 2019. Kawasaki disease: Characteristics, diagnosis, and unusual presentations. Expert Review of Clinical Immunology 15 (10): 1089\u20131104.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"6","key":"2276_CR4","first-page":"365","volume":"91","author":"A Saguil","year":"2015","unstructured":"Saguil, A., M. Fargo, and S. Grogan. 2015. Diagnosis and management of Kawasaki disease. American Family Physician 91 (6): 365\u2013371.","journal-title":"American Family Physician"},{"issue":"7","key":"2276_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas, M., and M. Arditi. 2020. Kawasaki disease: Pathophysiology and insights from mouse models. Nature Reviews Rheumatology 16 (7): 391\u2013405.","journal-title":"Nature Reviews Rheumatology"},{"issue":"3","key":"2276_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/1744666X.2017.1232165","volume":"13","author":"S Agarwal","year":"2016","unstructured":"Agarwal, S., and D.K. Agrawal. 2016. Kawasaki disease: Etiopathogenesis and novel treatment strategies. Expert Review of Clinical Immunology 13 (3): 247\u2013258.","journal-title":"Expert Review of Clinical Immunology"},{"key":"2276_CR7","doi-asserted-by":"publisher","first-page":"981010","DOI":"10.3389\/fcvm.2022.981010","volume":"9","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y., Y. Zhang, Y. Li, Y. Hua, and Y. Zhang. 2022. Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis. Frontiers in Cardiovascular Medicine 9:981010.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"5","key":"2276_CR8","doi-asserted-by":"publisher","first-page":"166707","DOI":"10.1016\/j.bbadis.2023.166707","volume":"1869","author":"X Liu","year":"2023","unstructured":"Liu, X., T. Luo, Z. Fan, J. Li, Y. Zhang, G. Lu, M. Lv, S. Lin, Z. Cai, J. Zhang, K. Zhou, J. Guo, Y. Hua, Y. Zhang, and Y. Li. 2023. Single cell RNA-seq resolution revealed CCR1(+)\/SELL(+)\/XAF(+) CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (5): 166707.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"2276_CR9","doi-asserted-by":"publisher","first-page":"132364","DOI":"10.1016\/j.ijcard.2024.132364","volume":"413","author":"L Yu","year":"2024","unstructured":"Yu, L., Y. Li, Y. Zhang, L. Weng, D. Shuai, J. Zhu, C. Niu, M. Chu, and C. Jia. 2024. Human cytomegalovirus pUL135 protein affects endothelial cell function via CD2AP in Kawasaki disease. International Journal of Cardiology 413:132364.","journal-title":"International Journal of Cardiology"},{"issue":"17","key":"2276_CR10","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle, B.W., A.H. Rowley, J.W. Newburger, J.C. Burns, A.F. Bolger, M. Gewitz, A.L. Baker, M.A. Jackson, M. Takahashi, P.B. Shah, T. Kobayashi, M.H. Wu, T.T. Saji, and E. Pahl. 2017. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation 135 (17): e927\u2013e999.","journal-title":"Circulation"},{"issue":"6","key":"2276_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian, F. 2005. NFAT proteins: key regulators of T-cell development and function. Nature Reviews Immunology 5 (6): 472\u2013484.","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"2276_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pcad.2012.07.006","volume":"55","author":"H El Chami","year":"2012","unstructured":"El Chami, H., and P.M. Hassoun. 2012. Immune and inflammatory mechanisms in pulmonary arterial hypertension. Progress in Cardiovascular Diseases 55 (2): 218\u2013228.","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"4","key":"2276_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jb\/mvu006","volume":"155","author":"T Minami","year":"2014","unstructured":"Minami, T. 2014. Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated? Journal of Biochemistry 155 (4): 217\u2013226.","journal-title":"Journal of Biochemistry"},{"issue":"1","key":"2276_CR14","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41598-020-61667-y","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang, Y., J. Hu, J. Liu, Z. Geng, Y. Tao, F. Zheng, Y. Wang, S. Fu, W. Wang, C. Xie, Y. Zhang, and F. Gong. 2020. The role of Ca(2+)\/NFAT in dysfunction and inflammation of human coronary endothelial cells induced by Sera from patients with Kawasaki disease. Scientific Reports 10 (1): 4706.","journal-title":"Scientific Reports"},{"key":"2276_CR15","doi-asserted-by":"publisher","first-page":"1090056","DOI":"10.3389\/fimmu.2022.1090056","volume":"13","author":"H Huang","year":"2023","unstructured":"Huang, H., J. Dong, J. Jiang, F. Yang, Y. Zheng, S. Wang, N. Wang, J. Ma, M. Hou, Y. Ding, L. Meng, W. Zhuo, D. Yang, W. Qian, Q. Chen, G. You, G. Qian, L. Gu, and H. Lv. 2023. The role of FOXO4\/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease. Frontiers in Immunology 13:1090056.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2276_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13578-022-00870-y","volume":"12","author":"M Sun","year":"2022","unstructured":"Sun, M., and X. Zhang. 2022. Current methodologies in protein ubiquitination characterization: from ubiquitinated protein to ubiquitin chain architecture. Cell & Bioscience 12 (1): 126.","journal-title":"Cell & Bioscience"},{"issue":"5","key":"2276_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molmed.2019.02.002","volume":"25","author":"Y Fujita","year":"2019","unstructured":"Fujita, Y., R. Tinoco, Y. Li, D. Senft, and Z.A. Ronai. 2019. Ubiquitin ligases in cancer immunotherapy - balancing antitumor and autoimmunity. Trends in Molecular Medicine 25 (5): 428\u2013443.","journal-title":"Trends in Molecular Medicine"},{"issue":"3","key":"2276_CR18","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder, N.A., and G.M. Silva. 2021. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response. Journal of Biological Chemistry 297 (3): 101077.","journal-title":"Journal of Biological Chemistry"},{"key":"2276_CR19","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2024.2","volume":"26","author":"X Zhan","year":"2024","unstructured":"Zhan, X., Y. Yang, Q. Li, and F. He. 2024. The role of deubiquitinases in cardiac disease. Expert Reviews in Molecular Medicine 26:e3.","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"1","key":"2276_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCULATIONAHA.123.063760","volume":"148","author":"W Zhang","year":"2023","unstructured":"Zhang, W., J. Zhao, L. Deng, N. Ishimwe, J. Pauli, W. Wu, S. Shan, W. Kempf, M.D. Ballantyne, D. Kim, Q. Lyu, M. Bennett, J. Rodor, A.W. Turner, Y.W. Lu, P. Gao, M. Choi, G. Warthi, H.W. Kim, M.M. Barroso, W.B. Bryant, C.L. Miller, N.L. Weintraub, L. Maegdefessel, J.M. Miano, A.H. Baker, and X. Long. 2023. INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10. Circulation 148 (1): 47\u201367.","journal-title":"Circulation"},{"issue":"12","key":"2276_CR21","doi-asserted-by":"publisher","first-page":"105370","DOI":"10.1016\/j.jbc.2023.105370","volume":"299","author":"N Cheng","year":"2023","unstructured":"Cheng, N., and J. Trejo. 2023. An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses. Journal of Biological Chemistry 299 (12): 105370.","journal-title":"Journal of Biological Chemistry"},{"key":"2276_CR22","doi-asserted-by":"publisher","first-page":"104557","DOI":"10.1016\/j.phrs.2019.104557","volume":"157","author":"F Ning","year":"2020","unstructured":"Ning, F., H. Xin, J. Liu, C. Lv, X. Xu, M. Wang, Y. Wang, W. Zhang, and X. Zhang. 2020. Structure and function of USP5: Insight into physiological and pathophysiological roles. Pharmacological Research 157:104557.","journal-title":"Pharmacological Research"},{"key":"2276_CR23","doi-asserted-by":"publisher","first-page":"101944","DOI":"10.1016\/j.mcp.2023.101944","volume":"73","author":"ST Gao","year":"2024","unstructured":"Gao, S.T., X. Xin, Z.Y. Wang, Y.Y. Hu, and Q. Feng. 2024. USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities. Molecular and Cellular Probes 73:101944.","journal-title":"Molecular and Cellular Probes"},{"issue":"8","key":"2276_CR24","doi-asserted-by":"publisher","first-page":"e0193","DOI":"10.1097\/HC9.0000000000000193","volume":"7","author":"S Shi","year":"2023","unstructured":"Shi, S., X. Pan, M. Chen, L. Zhang, S. Zhang, X. Wang, S. Shi, Z. Chen, W. Lin, and Y. Jiang. 2023. USP5 promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein. Hepatology Communications 7 (8): e0193.","journal-title":"Hepatology Communications"},{"key":"2276_CR25","doi-asserted-by":"publisher","first-page":"111225","DOI":"10.1016\/j.cellsig.2024.111225","volume":"120","author":"H Guo","year":"2024","unstructured":"Guo, H., R. Liu, H. Lv, Q. Huo, Y. Yao, and X. Lu. 2024. USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination. Cellular Signalling 120:111225.","journal-title":"Cellular Signalling"},{"issue":"7","key":"2276_CR26","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1038\/s41390-022-02341-z","volume":"93","author":"C Huang","year":"2022","unstructured":"Huang, C., W. Wang, H. Huang, J. Jiang, Y. Ding, X. Li, J. Ma, M. Hou, X. Pu, G. Qian, and H. Lv. 2022. Kawasaki disease: ubiquitin-specific protease 5 promotes endothelial inflammation via TNF\u03b1-mediated signaling. Pediatric Research 93 (7): 1883\u20131890.","journal-title":"Pediatric Research"},{"issue":"1","key":"2276_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12016-024-08985-5","volume":"66","author":"R Kumrah","year":"2024","unstructured":"Kumrah, R., T. Goyal, A. Rawat, and S. Singh. 2024. Markers of endothelial dysfunction in Kawasaki disease: An update. Clinical Reviews in Allergy & Immunology 66 (1): 99\u2013111.","journal-title":"Clinical Reviews in Allergy & Immunology"},{"issue":"12","key":"2276_CR28","doi-asserted-by":"publisher","first-page":"e009562","DOI":"10.1136\/bmjopen-2015-009562","volume":"5","author":"R Aoyagi","year":"2015","unstructured":"Aoyagi, R., H. Hamada, Y. Sato, H. Suzuki, Y. Onouchi, R. Ebata, K. Nagashima, M. Terauchi, M. Terai, H. Hanaoka, and A. Hata. 2015. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial). BMJ Open 5 (12): e009562.","journal-title":"BMJ Open"},{"key":"2276_CR29","doi-asserted-by":"publisher","first-page":"156304","DOI":"10.1016\/j.cyto.2023.156304","volume":"169","author":"Y Sun","year":"2023","unstructured":"Sun, Y., Y. Tao, Z. Geng, F. Zheng, Y. Wang, Y. Wang, S. Fu, W. Wang, C. Xie, Y. Zhang, and F. Gong. 2023. The activation of CaN\/NFAT signaling pathway in macrophages aggravated Lactobacillus casei cell wall extract-induced Kawasaki disease vasculitis. Cytokine 169:156304.","journal-title":"Cytokine"},{"issue":"3","key":"2276_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000053823","volume":"125","author":"Y Inoue","year":"2001","unstructured":"Inoue, Y., H. Kimura, M. Kato, Y. Okada, and A. Morikawa. 2001. Sera from patients with Kawasaki disease induce intercellular adhesion molecule-1 but not Fas in human endothelial cells. International Archives of Allergy and Immunology 125 (3): 250\u2013255.","journal-title":"International Archives of Allergy and Immunology"},{"issue":"2","key":"2276_CR31","doi-asserted-by":"publisher","first-page":"2264315","DOI":"10.1080\/07853890.2023.2264315","volume":"55","author":"XB Huang","year":"2023","unstructured":"Huang, X.B., S. Zhao, Z.Y. Liu, Y.Y. Xu, and F. Deng. 2023. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease. Annals of Medicine 55 (2): 2264315.","journal-title":"Annals of Medicine"},{"key":"2276_CR32","doi-asserted-by":"publisher","first-page":"156280","DOI":"10.1016\/j.cyto.2023.156280","volume":"169","author":"S Kaneko","year":"2023","unstructured":"Kaneko, S., M. Shimizu, A. Shimbo, H. Irabu, K. Yokoyama, K. Furuno, T. Tanaka, K. Ueno, S. Fujita, N. Iwata, J. Fujimura, K. Akamine, M. Mizuta, Y. Nakagishi, T. Minato, K. Watanabe, A. Kobayashi, T. Endo, K. Tabata, M. Mori, and T. Morio. 2023. Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers. Cytokine 169:156280.","journal-title":"Cytokine"},{"issue":"1","key":"2276_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-00418-x","volume":"6","author":"J Liu","year":"2021","unstructured":"Liu, J., Y. Cheng, M. Zheng, B. Yuan, Z. Wang, X. Li, J. Yin, M. Ye, and Y. Song. 2021. Targeting the ubiquitination\/deubiquitination process to regulate immune checkpoint pathways. Signal Transduction and Targeted Therapy 6 (1): 28.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"2276_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F., J. Chen, K. Li, H. Li, Y. Zhu, Y. Zhai, B. Lu, Y. Fan, Z. Liu, X. Chen, X. Jia, Z. Dong, and K. Liu. 2024. Ubiquitination and deubiquitination in cancer: From mechanisms to novel therapeutic approaches. Molecular Cancer 23 (1): 148.","journal-title":"Molecular Cancer"},{"issue":"10","key":"2276_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1042\/BCJ20210735","volume":"479","author":"K Newton","year":"2022","unstructured":"Newton, K., and A.D. Gitlin. 2022. Deubiquitinases in cell death and inflammation. Biochemical Journal 479 (10): 1103\u20131119.","journal-title":"Biochemical Journal"},{"key":"2276_CR36","doi-asserted-by":"publisher","first-page":"8295149","DOI":"10.1155\/2020\/8295149","volume":"2020","author":"XB Luo","year":"2020","unstructured":"Luo, X.B., J.C. Xi, Z. Liu, Y. Long, L.T. Li, Z.P. Luo, and D.H. Liu. 2020. Proinflammatory effects of ubiquitin-specific protease 5 (USP5) in rheumatoid arthritis fibroblast-like synoviocytes. Mediators of Inflammation 2020:8295149.","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"2276_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","volume":"20","author":"HJ Kim","year":"2023","unstructured":"Kim, H.J., H. Kim, J.H. Lee, and C. Hwangbo. 2023. Toll-like receptor 4 (TLR4): New insight immune and aging. Immunity & Ageing 20 (1): 67.","journal-title":"Immunity & Ageing"},{"issue":"9","key":"2276_CR38","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1002\/iid3.1032","volume":"11","author":"F Si","year":"2023","unstructured":"Si, F., Y. Lu, Y. Wen, T. Chen, Y. Zhang, and Y. Yang. 2023. Cathelicidin (LL-37) causes expression of inflammatory factors in coronary artery endothelial cells of Kawasaki disease by activating TLR4-NF-\u03baB-NLRP3 signaling. Immunity, Inflammation and Disease 11 (9): e1032.","journal-title":"Immunity, Inflammation and Disease"},{"key":"2276_CR39","doi-asserted-by":"publisher","first-page":"3296437","DOI":"10.1155\/2016\/3296437","volume":"2016","author":"F Gao","year":"2016","unstructured":"Gao, F., F. Si, S. Feng, Q. Yi, and R. Liu. 2016. Resistin enhances inflammatory cytokine production in coronary artery tissues by activating the NF-\u03baB signaling. BioMed Research International 2016:3296437.","journal-title":"BioMed Research International"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02276-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:12:43Z","timestamp":1762881163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02276-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2276"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02276-7","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the ethical review committee of the Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University). Written informed consent was obtained from all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Animal studies were performed in compliance with the ARRIVE guidelines and the Basel Declaration. All animals received humane care according to the National Institutes of Health (USA) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}},{"value":"The research has been carried out in accordance with the World Medical Association Declaration of Helsinki, and that all subjects provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Rights Statements and Informed Consent"}},{"value":"Not available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All of us authors agree to publish this article in this journal.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.\u2019","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}